Physician profile
John M Wray
NPI 1366436131
$1,477.84
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $138 · 2022: $652.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $262.20 | 2019 | |
| Horizon Therapeutics Plc | $213.61 | 2020-2022 | |
| Triad Life Sciences INC. | $163.18 | 2022 | |
| Royal Biologics, INC. | $119.39 | 2019 | |
| Angiodynamics, INC. | $107.22 | 2022 | |
| Tactile Systems Technology INC | $106.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $98.36 | 2022 | |
| Medline Industries LP | $94.14 | 2019 | |
| Cardiovascular Systems INC. | $90.92 | 2022 | |
| Orthofix Medical, INC. | $84.21 | 2019 | |
| Collaborative Care Diagnostics, LLC | $47.99 | 2022 | |
| Abbott Laboratories | $46.01 | 2022 | |
| Osteomed LLC | $22.34 | 2020 | |
| Seaspine Orthopedics Corporation | $21.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.